Andreas Münch Selected Research

Microscopic Colitis

1/2022	Pathogenesis of Microscopic Colitis: A Systematic Review.
2/2021	European guidelines on microscopic colitis: United European Gastroenterology and European Microscopic Colitis Group statements and recommendations.
1/2021	Budesonide as induction therapy for incomplete microscopic colitis: A randomised, placebo-controlled multicentre trial.
1/2021	Patients With Microscopic Colitis Have Altered Levels of Inhibitory and Stimulatory Biomarkers in Colon Biopsies and Sera Compared to Non-inflamed Controls.
11/2019	Single-centre experience with anti-tumour necrosis factor treatment in budesonide-refractory microscopic colitis patients.
3/2019	Vedolizumab in Refractory Microscopic Colitis: An International Case Series.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andreas Münch Research Topics

Disease

9	Collagenous Colitis 10/2021 - 03/2009
6	Microscopic Colitis 01/2022 - 03/2019
4	Inflammation (Inflammations) 01/2020 - 10/2007
4	Lymphocytic Colitis 01/2020 - 01/2015
2	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 10/2021 - 01/2020
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2020 - 04/2016
2	Necrosis 11/2019 - 03/2019
1	Ulcerative Colitis 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Rupture 01/2019
1	Abdominal Pain (Pain, Abdominal) 04/2016
1	Drug-Related Side Effects and Adverse Reactions 01/2016
1	Vitamin D Deficiency 10/2014
1	Critical Illness (Critically Ill) 10/2014
1	Hemorrhage 02/2010

Drug/Important Bio-Agent (IBA)

10	Budesonide (Pulmicort)FDA LinkGeneric 02/2021 - 03/2009
4	CollagenIBA 01/2020 - 01/2015
4	Methotrexate (Mexate)FDA LinkGeneric 03/2019 - 01/2012
3	Adalimumab (Humira)FDA Link 11/2019 - 01/2012
2	Phenobarbital (Luminal)FDA Link 01/2022 - 05/2015
2	Leukocyte L1 Antigen Complex (Calgranulin)IBA 10/2021 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2021
2	Bile Acids and Salts (Bile Acids)IBA 02/2021 - 10/2007
1	Lipocalin-2IBA 10/2021
1	Immunologic Factors (Immunomodulators)IBA 02/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	aquaporin 8IBA 07/2020
1	Aquaporins (Water Channels)IBA 07/2020
1	Infliximab (Remicade)FDA Link 11/2019
1	Factor VII (Proconvertin)IBA 11/2019
1	Azathioprine (Imuran)FDA LinkGeneric 03/2019
1	vedolizumabIBA 03/2019
1	PolymersIBA 01/2019
1	Mesalamine (Mesalazine)FDA LinkGeneric 12/2018
1	Capsules (Microcapsules)IBA 01/2016
1	CytokinesIBA 05/2015
1	Cholestyramine Resin (Questran)FDA LinkGeneric 05/2015
1	Loperamide (Imodium)FDA LinkGeneric 05/2015
1	Cholecalciferol (Vitamin D3)FDA Link 10/2014
1	Vitamin D FDA LinkGeneric 10/2014
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 02/2010
1	Clopidogrel (Plavix)FDA Link 02/2010
1	AntigensIBA 10/2007

Therapy/Procedure

6	Therapeutics 01/2021 - 02/2010
1	Length of Stay 10/2014
1	Operative Surgical Procedures 02/2010